Determination of the concentration of different drugs in the clinical environment of intensive care medicine and anesthesiology

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035148

Enrollment

100

Registered

2025-08-11

Start date

2025-04-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exploratory analysis of patient-specific factors influencing plasma levels of routinely used drugs in the anesthesiology and intensive care.

Interventions

Group 1: Prospective observational study of patients undergoing drug therapy as part of perioperative anesthesiology care in the operating room and/or intensive care unit.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Written consent to the study by the patients or their legal representatives

Exclusion criteria

Exclusion criteria: - Blood donors or participants in other studies in the past three months. - Pregnancy

Design outcomes

Primary

Measure	Time frame
Exploratory determination of plasma levels of drugs used in clinical routine, for example for pain therapy (e.g. metamizole), sedation (e.g. esketamine) or other substance groups.	—

Secondary

Measure	Time frame
no secondary outcome.	—

Countries

Germany

Contacts

Public ContactAndreas P. Wehrfritz

Anästhesiologische Klinik, Universitätsklinik Erlangen

andreas.wehrfritz@uk-erlangen.de004991318533680

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026